Changes in PTEN cellular levels, and related cellular compartmentation, have also been implicated in prominent diseases such as diabetes and neurological disorders including Parkinson’s disease and Alzheimer’s disease [63, 105, 107, 119–121]. Here, PTEN is linked to early-onset autosomal dominant Alzheimer disease.